In Vivo Toxicology Market: Global Industry Analysis and Forecast (2022-2029)

In Vivo Toxicology Market is expected to reach US$ 7.74 Bn. at a CAGR of 5.5% during the forecast period 2029.

Global In Vivo Toxicology Market Overview:

The study of toxic effects of chemicals in non-human living organisms is known as in vivo toxicology. The use of living organisms to search for the existence of harmful or carcinogenic chemicals in new substances, as well as the impact of new substances on humans, is known as in-vivo toxicology research. These checks can also be used to ensure that the medication or product of choice does not contain any harmful chemicals. In-vivo testing is popular in pre-clinical studies. Primary in vivo toxicology tests aid in determining a drug's effects before first-in-human use. In vivo toxicological experiments are carried out on guinea pigs, rats, rabbits, and other animals using a variety of exposure methods, including intravenous, topical, intramuscular, and others. Animal studies are carried out to see how industrial and environmental toxins affect the immune system. A rise in R&D activities to find new drugs and vaccines has resulted from increasing demand for novel therapeutics. Testing of a drug in animals has been made obligatory by government regulatory bodies to prevent late-stage failures of a new drug and is, therefore, the market's main engine. However, animal models have been found to have some disadvantages as opposed to in vitro studies, which could affect market development. In Vivo Toxicology MarketTo know about the Research Methodology :- Request Free Sample Report Clinical trials are increasing in number all the time. According to ClinicalTrials.gov, a total number of 325,797 trails are registered on the database as of December 2021. The Center for Drug Evaluation and Research (CDER) approved 48 new drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs), in 2021. Regulatory agencies have adopted strict protocols for animal research in recent years. Pharmaceutical companies must perform a thorough investigation into the impact of molecules on living organisms.

Global In Vivo Toxicology Market Dynamics:

Drivers:

The growth of the global in-vivo toxicology market is fueled by factors such as rising research and development costs for detecting early-stage toxicity during the drug development phase, technical advances, and anti-animal testing sentiment. Furthermore, the development of novel in vivo toxicology studies are expected to boost the global demand for in vivo toxicology. The increase in oncology research, the increased emphasis on the advancement of personalized medicine, and the demand for humanized animal models can all help the in vivo toxicology market grow. Changing trends in the global healthcare markets have forced pharmaceutical and biotechnology companies to create products that provide tangible value rather than only incremental benefits. As a result, a growing number of pharmaceutical and medical device companies are focusing on innovation and improving their R&D performance. According to the Biotechnology Industry Organization (BIO) 2021, R&D for new therapeutics and innovative drugs accounted for approximately 82.7 percent of venture capital investment in the United States by emerging growth companies (EGCs) over the last decade. Similarly, designing biologic molecules/metabolites received 50% of venture capital investment in therapeutics. So, the Pharma and Biotechnology companies are also investing in research to advance novel molecules to serve to growing demands in the healthcare domain.

Restraints:

However, the disadvantages of animal testing and the growing demand to develop and implement alternative animal testing methods can limit the global in vivo toxicology market's development. Animal use in in vivo toxicology testing is being replaced, reduced, or refined by researchers and toxicology experts. The Organization for Economic Co-operation and Development (OECD), the European Centre for the Validation of Alternative Methods (ECVAM), and the Interagency Coordinating Committee on the Validation of Alternative Methods have developed validation criteria for tests (ICCVAM).

Alternative tests include:

o In vitro test: These experiments are carried out in laboratories using different lab equipment in a controlled environment outside of a living organism. o Ex vivo test: These experiments are carried out in or on tissues from animals in the wild, with only minor changes to the natural environment. o In silico test: These experiments are performed using computer simulation. In the coming years, the growing acceptance of alternative methods for toxicology research is expected to reduce the demand for animal models, which will affect the in vivo toxicology industry.

Global In Vivo Toxicology Market Segment Analysis:

Based on the Product, the global in vivo toxicology market is fragmented into consumables and instruments. The consumables segment is further fragmented into animal models, reagents & kits. Animal models are divided into three categories: rabbits, rats, and other species. In 2021, the consumables segment of the in vivo toxicology market had the largest share. The widespread use of reagents and kits in research activities, as well as an increase in funding for research projects and their widespread use in in vivo toxicology studies, are driving this segment's development. Based on the Test Type, The global in vivo toxicology market is segmented into acute, sub-acute, chronic, and sub-chronic test types. The chronic test type segment category dominated the market in 2021, followed by the sub-chronic test type. The chronic test form market is growing due to increased research on drugs used for longer-duration treatment, such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives. Based on the Testing Facility, the global in vivo toxicology market is fragmented into outsourced testing facilities and in-house testing facilities. The outsourced testing facility segment accounted for the largest share in the market, in 2021. The large share of this segment can be attributed to pharmaceutical, biopharmaceutical, and medical device companies' increased R&D expenditures and cost-cutting strategies, resulting in increased outsourcing of services to CROs. Based on the Toxicity End Point, the global in vivo toxicology market is fragmented into ADME (Absorption, Distribution, metabolism, and Excretion), immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, and developmental & reproductive toxicity. The immunotoxicity segment dominated the global in vivo toxicology market in 2021, led by the systemic toxicity segment. The immunotoxicity segment is expanding due to increased demand for biologics and biosimilars. Based on the End Users, the global in vivo toxicology market is categorized into academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, food industry, and chemical industry. In 2021, the segment of academic and research institutes held the largest share of the in vivo toxicology market. The increase in the number of research activities in the field of in vivo toxicology, as well as funding to academic and research institutes to perform in vivo toxicology research.

Global In Vivo Toxicology Market Regional Insights:

In 2021, North America, which includes the US and Canada, has the largest share of the global in vivo toxicology market, followed by Europe. The area benefits from the presence of major players operating in the US, growing biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies in the region, significant government support, mandatory toxicology testing rules, and simplified toxicology guidelines, resulting in a higher number of studies. North America, especially the United States, had the highest demand for in vivo toxicology products. North America has the highest revenue share, accounting for over 40% of total revenue, followed by Europe, which accounts for 30% of total revenue. In any given sector, over 99 percent of consumption is seen in ADME, safety pharmacology, and genotoxicity are the three primary fields. During the forecast era, Asia Pacific is projected to be the highest augmentation in the Vivo toxicology market. Several global pharmaceutical companies have joined the APAC market to take advantage of the substantial growth opportunities in emerging Asian countries while also lowering their production costs by relocating their drug development R&D and manufacturing operations to the area. Some of the major factors driving this development are a large number of trained researchers and low-cost operations in APAC countries such as India and China. Furthermore, this demand is expected to expand moderately in the Middle East and Africa, as well as South America, in the coming years. The objective of the report is to present a comprehensive analysis of the global in vivo toxicology market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global in vivo toxicology market dynamics, structure by analyzing the market segments and project the global in vivo toxicology market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global in vivo toxicology market make the report investor’s guide.

Global In Vivo Toxicology Market Key Developments:

The non-clinical CRO services of Envigo were acquired by Covance in June 2021. The company was able to broaden its service offerings and grow its customer base as a result of this acquisition.

Global In Vivo Toxicology Market Scope: Inquire before buying

In Vivo Toxicology Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 5.04 Bn.
Forecast Period 2022 to 2029 CAGR: 5.5% Market Size in 2029: US $ 7.74 Bn.
Segments Covered: by Product • Consumables • Instruments
by Test Type • Acute • Sub-Acute • Sub-Chronic • Chronic Test Type
by Testing Facility • Outsourced Testing Facility • Inhouse Testing Facility
by Toxicity End Point • ADME (Absorption, Distribution, Metabolism, and Excretion) • Immunotoxicity • Systemic Toxicity • Carcinogenicity • Genotoxicity
by End Users • Academic and Research Institutes • Pharmaceutical and Biotechnology Companies • Contract Research Organizations • Food Industry • Chemical Industry

Global In Vivo Toxicology Market, by Region:

• North America • Europe • Asia Pacific • South America • The Middle East and Africa

Global In Vivo Toxicology Market Key Players:

PerkinElmer • Labcorp • Eurofins Scientific • Charles River Laboratories • The Jackson Laboratory • Envigo • Taconic Biosciences, Inc • JANVIER LABS • Thermo Fisher Scientific • Danaher Corporation • Waters Corporation • Agilent Technologies • Shimadzu Corporation • Bruker Corporation • Merck KGaA • GE Healthcare • Bio-Rad Laboratories • genOway • Cyagen Biosciences • GVK BIO • PolyGene • Crown Biosciences • TransCure bioServices • Ozgene Pty Ltd. • Harbour BioMed Frequently Asked Questions: 1. Which region has the largest share in Global In Vivo Toxicology Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global In Vivo Toxicology Market? Ans: The Global In Vivo Toxicology Market is growing at a CAGR of 5.5% during forecasting period 2022-2029. 3. What is scope of the Global In Vivo Toxicology market report? Ans: Global In Vivo Toxicology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global In Vivo Toxicology market? Ans: The important key players in the Global In Vivo Toxicology Market are – PerkinElmer, Labcorp, Eurofins Scientific, Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc, JANVIER LABS, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, Merck KGaA, GE Healthcare, Bio-Rad Laboratories, genOway, Cyagen Biosciences, GVK BIO, PolyGene, Crown Biosciences, TransCure bioServices, Ozgene Pty Ltd., and Harbour BioMed 5. What is the study period of this market? Ans: The Global In Vivo Toxicology Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global In Vivo Toxicology Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Flow Cytometry Products Market 3.4. Geographical Snapshot of the Flow Cytometry Products Market, By Manufacturer share 4. Global In Vivo Toxicology Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Flow Cytometry Products Market 5. Supply Side and Demand Side Indicators 6. Global In Vivo Toxicology Market Analysis and Forecast, 2021-2029 6.1. Global In Vivo Toxicology Market Size & Y-o-Y Growth Analysis. 7. Global In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 7.1.1. Consumables 7.1.1.1. Animal models 7.1.1.2. Reagents 7.1.1.3. kits 7.1.2. Instruments 7.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 7.2.1. Acute 7.2.2. Sub-Acute 7.2.3. Sub-Chronic 7.2.4. Chronic Test Type 7.2.5. others 7.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 7.3.1. Outsourced Testing facility 7.3.2. Inhouse Testing facility 7.3.3. Others 7.4. Market Size (Value) Estimates & Forecast By Toxicity and End Point, 2021-2029 7.4.1. ADME (Absorption, Distribution, Metabolism , and Excretion) 7.4.2. Immunotoxicity 7.4.3. Systemic Toxicity 7.4.4. Carcinogenicity 7.4.5. Genotoxicity 7.4.6. Developmental & Reproductive Toxicity 7.4.7. Others 7.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 7.5.1. Academic and Research Institutes 7.5.2. Pharmaceutical and Biotechnology Companies 7.5.3. Contract Research Organizations 7.5.4. Food Industry 7.5.5. Chemical Industry 7.5.6. Others 8. Global In Vivo Toxicology Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 9.1.1. Consumables 9.1.1.1. Animal Models 9.1.1.2. Reagents 9.1.1.3. kits 9.1.2. Instruments 9.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 9.2.1. Acute 9.2.2. Sub-Acute 9.2.3. Sub-Chronic 9.2.4. Chronic Test Type 9.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 9.3.1. Academic and clinical research applications 9.3.1.1. Outsourced Testing Facility 9.3.1.2. Inhouse Testing Facility 9.3.1.3. Others 9.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 9.4.1. ADME (Absorption, Distribution, Metabolism, and Excretion) 9.4.2. Immunotoxicity 9.4.3. Systemic Toxicity 9.4.4. Carcinogenicity 9.4.5. Genotoxicity 9.4.6. Developmental & Reproductive Toxicity 9.4.7. Others 9.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 9.5.1. Academic and Research Institutes 9.5.2. Pharmaceutical and Biotechnology Companies 9.5.3. Contract Research Organizations 9.5.4. Food Industry 9.5.5. Chemical Industry 9.5.6. others 10. North America In Vivo Toxicology Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 11.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 11.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 11.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 12. Canada In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 12.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 12.4. Market Size (Value) Estimates & Forecast By Toxicity end Point, 2021-2029 12.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 13. Mexico In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 13.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 13.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 13.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 14. Europe In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 14.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 14.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 14.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 15. Europe In Vivo Toxicology Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 16.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 16.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 16.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 17. France In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 17.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 17.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 17.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 18. Germany In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 18.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 18.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 18.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 19. Italy In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 19.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 19.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 19.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 20. Spain In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 20.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 20.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 20.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 21. Sweden In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 21.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 21.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 21.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 22. CIS Countries In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 22.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 22.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 22.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 23. Rest of Europe In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 23.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 23.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 23.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 24. Asia Pacific In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 24.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 24.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 24.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 25. Asia Pacific In Vivo Toxicology Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 26.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 26.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 26.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 27. India In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 27.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 27.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 27.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 28. Japan In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 28.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 28.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 28.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 29. South Korea In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 29.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 29.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 29.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 30. Australia In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 30.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 30.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 30.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 31. ASEAN In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 31.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 31.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 31.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 32. Rest of Asia Pacific In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 32.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 32.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 32.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 33. Middle East Africa In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 33.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 33.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 33.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 34. Middle East Africa In Vivo Toxicology Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 35.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 35.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 35.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 36. GCC Countries In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 36.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 36.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 36.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 37. Egypt In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 37.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 37.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 37.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 38. Nigeria In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 38.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 38.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 38.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 39. Rest of ME&A In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 39.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 39.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 39.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 40. South America In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 40.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 40.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 40.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 41. South America In Vivo Toxicology Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 42.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 42.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 42.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 43. Argentina In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 43.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 43.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 43.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 44. Rest of South America In Vivo Toxicology Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By Test Type, 2021-2029 44.3. Market Size (Value) Estimates & Forecast By Testing Facility, 2021-2029 44.4. Market Size (Value) Estimates & Forecast By Toxicity End Point, 2021-2029 44.5. Market Size (Value) Estimates & Forecast By End users, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global In Vivo Toxicology Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Testing Facilities and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Charles River Laboratories 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. PerkinElmer 45.3.3. Labcorp 45.3.4. Eurofins Scientific 45.3.5. The Jackson Laboratory 45.3.6. Envigo 45.3.7. Taconic Biosciences, Inc 45.3.8. JANVIER LABS 45.3.9. Danaher Corporation 45.3.10. Waters Corporation 45.3.11. Agilent Technologies 45.3.12. Shimadzu Corporation 45.3.13. Bruker Corporation 45.3.14. Merck KGaA 45.3.15. GE Healthcare 45.3.16. Bio-Rad Laboratories 45.3.17. genOway 45.3.18. Cyagen Biosciences 45.3.19. GVK BIO 45.3.20. PolyGene 45.3.21. Crown Biosciences 45.3.22. TransCure bioServices 45.3.23. Ozgene Pty Ltd 45.3.24. Harbour BioMed 45.3.25. Thermo Fisher Scientific, Inc. 45.3.26. Other Key Players 46. Primary Key Insights
  • INQUIRE BEFORE BUYING